Business ❯ Corporate Law ❯ Securities

Investor Relations

Class Action Lawsuits Public Companies Financial Reporting Litigation Class Action Lawsuit Stockholder Rights Fraudulent Statements Shareholder Actions Legal Compliance Fraudulent Practices

Investors Sue After FDA Says Capricor Altered Pre‑Specified Trial Analysis

Law firms are seeking lead‑plaintiff status to recover losses after the FDA said key trial analyses were finalized late and treated as post‑hoc.

Investors Sue AppLovin Over Alleged Misleading Claims About AI Model Progress

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

Class Action Filed Against GRAIL Over NHS‑Galleri Trial Disclosures as Law Firms Seek Lead Plaintiffs

Multiple Law Firms File Class Action Over Lucid’s Disclosure of Gravity Delivery Problems

Law Firms File Securities Suits Against AeroVironment Over Alleged Misleading Space‑Program Claims

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Investor Lawsuits Target ODDITY Over Ad-Algorithm Disruption as Lead-Plaintiff Deadline Nears

Nektar Securities Suit Urges Investors To Seek Lead‑Plaintiff Status Before May 5

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Richtech Investors Face Friday Deadline in Lawsuit Over Microsoft Tie Claims

Richtech Robotics Faces Wave of Securities Suits Over Microsoft Claims as Lead Plaintiff Deadline Nears

Integer Securities Class Action Moves Forward as Investors Face Feb. 9 Lead-Plaintiff Deadline

Stride Securities Fight Intensifies as Firms Urge Investors to Meet Jan. 12 Lead-Plaintiff Deadline

F5 Investors Face Feb. 17 Deadline in Securities Case Over Nation‑State Breach Disclosure

Stride Securities Suits Draw Investor Outreach Before Jan. 12 Filing Cutoff

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action

LifeMD Securities Suit Intensifies as Lead Plaintiff Deadline Nears